1. Home
  2. VVOS
  3. VVOS News

Latest Vivos Therapeutics Inc. (VVOS) News on April 2, 2025

Vivos Therapeutics Full Year 2024 Earnings: Misses Expectations
VVOS

Simply Wall St.

11 hours ago

Vivos Therapeutics Full Year 2024 Earnings: Misses Expectations

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates
VVOS

Zacks

2 days ago

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

2 days ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
VVOS

GlobeNewswire

5 days ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
VVOS

GlobeNewswire

a month ago

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
VVOS

GlobeNewswire

a month ago

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.

Best Momentum Stocks to Buy for January 8th
VVOS

Zacks

3 months ago

Best Momentum Stocks to Buy for January 8th

VVOS

MT Newswires

3 months ago

Vivos Therapeutics Launches $3.5 Million Registered Direct Offering

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
VVOS

GlobeNewswire

3 months ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy
VVOS

Zacks

3 months ago

All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy

Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
VVOS

Simply Wall St.

5 months ago

Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

VVOS

GuruFocus.com

5 months ago

Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

5 months ago

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
VVOS

GlobeNewswire

5 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
VVOS

GlobeNewswire

6 months ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

VVOS

MT Newswires

6 months ago

Vivos Therapeutics Prices $4.3 Million Common Stock Offering; Shares Fall Pre-Bell

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
VVOS

GlobeNewswire

6 months ago

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

VVOS

MT Newswires

6 months ago

Sector Update: Health Care

VVOS

MT Newswires

6 months ago

Update: Vivos Therapeutics' Shares Jump After FDA Clears Sleep Disorder Treatment Device

Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
VVOS

Benzinga

6 months ago

Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children

VVOS

MT Newswires

6 months ago

Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
VVOS

GlobeNewswire

6 months ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

8 months ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
VVOS

GlobeNewswire

8 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

VVOS

MT Newswires

8 months ago

Vivos Therapeutics Files Registration Statement for Secondary Sale of Securities

Vivos eyes human trials for radiation treatment gel with IDE submission
VVOS

Clinical Trials Arena

9 months ago

Vivos eyes human trials for radiation treatment gel with IDE submission

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
VVOS

GlobeNewswire

9 months ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
VVOS

GlobeNewswire

10 months ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Bayhorse Silver Underground Drill Program Assay Results - New Mineralized Zone Identified
VVOS

Newsfile

10 months ago

Bayhorse Silver Underground Drill Program Assay Results - New Mineralized Zone Identified

CloudPay Launches In-App Mobile Payslip Functionality to Enhance Employee Pay Experience
VVOS

Business Wire

10 months ago

CloudPay Launches In-App Mobile Payslip Functionality to Enhance Employee Pay Experience

How often should you change your banking passwords, really?
VVOS

Yahoo Personal Finance

10 months ago

How often should you change your banking passwords, really?

Nvidia begins trading Monday after 10-for-1 stock split
VVOS

Yahoo Finance

10 months ago

Nvidia begins trading Monday after 10-for-1 stock split

Biden's team asks CEOs how to further boost the economy while Trump says business is on his side
VVOS

Associated Press Finance

10 months ago

Biden's team asks CEOs how to further boost the economy while Trump says business is on his side

Ulta Beauty: A Debt-Free, Growing Business With Upside Potential
VVOS

GuruFocus.com

10 months ago

Ulta Beauty: A Debt-Free, Growing Business With Upside Potential

Costco's Upside Is Limited Due to Valuation
VVOS

GuruFocus.com

10 months ago

Costco's Upside Is Limited Due to Valuation

Landolt Space Mission: resolving astronomical-calibration problems
VVOS

CNW Group

10 months ago

Landolt Space Mission: resolving astronomical-calibration problems

Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors
VVOS

GlobeNewswire

10 months ago

Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors

VVOS

GuruFocus.com

a year ago

Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
VVOS

News Direct

a year ago

Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
VVOS

Insider Monkey

a year ago

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript

Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations
VVOS

Simply Wall St.

a year ago

Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

3 Stocks to Turn $1,000 Into $1 Million: February 2024
VVOS

InvestorPlace

a year ago

3 Stocks to Turn $1,000 Into $1 Million: February 2024

Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds

Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
VVOS

News Direct

a year ago

Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Credit Acceptance (CACC) Q4 Earnings and Revenues Top Estimates
VVOS

Zacks

a year ago

Credit Acceptance (CACC) Q4 Earnings and Revenues Top Estimates

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene
VVOS

GlobeNewswire

a year ago

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

CURO to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 7, 2024
VVOS

Business Wire

a year ago

CURO to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 7, 2024

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
VVOS

GlobeNewswire

a year ago

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

AgEagle Aerial Systems Appoints Chairman Grant Begley as Interim CEO
VVOS

GlobeNewswire

a year ago

AgEagle Aerial Systems Appoints Chairman Grant Begley as Interim CEO

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
VVOS

GlobeNewswire

a year ago

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

Increasing losses over year doesn't faze Generation Income Properties (NASDAQ:GIPR) investors as stock jumps 12% this past week
VVOS

Simply Wall St.

a year ago

Increasing losses over year doesn't faze Generation Income Properties (NASDAQ:GIPR) investors as stock jumps 12% this past week

Foresight CEO Letter to Shareholders
VVOS

GlobeNewswire

a year ago

Foresight CEO Letter to Shareholders

Addex to Present at the Swiss Equities Baader Conference
VVOS

GlobeNewswire

a year ago

Addex to Present at the Swiss Equities Baader Conference

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

Zacks Industry Outlook Highlights Dorian LPG, EuroDry and Kirby
VVOS

Zacks

a year ago

Zacks Industry Outlook Highlights Dorian LPG, EuroDry and Kirby

Addex to Present at Biotech Showcase™ 2024
VVOS

GlobeNewswire

a year ago

Addex to Present at Biotech Showcase™ 2024

3 Impressive Shipping Stocks Worth Betting on in 2024
VVOS

Zacks

a year ago

3 Impressive Shipping Stocks Worth Betting on in 2024

Ceragon Networks to Participate in the Needham Growth Conference
VVOS

PR Newswire

a year ago

Ceragon Networks to Participate in the Needham Growth Conference

Analysts Expect Breakeven For Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Before Long
VVOS

Simply Wall St.

a year ago

Analysts Expect Breakeven For Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Before Long

Linkage Global Inc Announces Closing of $6,000,000 Initial Public Offering
VVOS

GlobeNewswire

a year ago

Linkage Global Inc Announces Closing of $6,000,000 Initial Public Offering

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
VVOS

GuruFocus.com

a year ago

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc

Shareholders Should Be Pleased With Avino Silver & Gold Mines Ltd.'s (TSE:ASM) Price
VVOS

Simply Wall St.

a year ago

Shareholders Should Be Pleased With Avino Silver & Gold Mines Ltd.'s (TSE:ASM) Price

Presto Announces Stanford PhD and AI technologist Debarag Banerjee as Head of Voice Engineering
VVOS

GlobeNewswire

a year ago

Presto Announces Stanford PhD and AI technologist Debarag Banerjee as Head of Voice Engineering

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
VVOS

GlobeNewswire

a year ago

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

VVOS

GlobeNewswire

a year ago

Kaixin Auto Holdings Announces Establishing AI Automobile Research Institute to Formulate AI Development Strategy

36Kr Holdings Inc. (NASDAQ:KRKR) Q3 2023 Earnings Call Transcript
VVOS

Insider Monkey

a year ago

36Kr Holdings Inc. (NASDAQ:KRKR) Q3 2023 Earnings Call Transcript

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services
VVOS

Business Wire

a year ago

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023
VVOS

GlobeNewswire

a year ago

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)
VVOS

PR Newswire

a year ago

Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)

Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
VVOS

MedTech Dive

a year ago

Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea

VVOS

News Direct

a year ago

Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea

VVOS

Reuters

a year ago

UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea

VVOS

Reuters

a year ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
VVOS

Business Wire

a year ago

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

TOP Ships Inc. Announces Extension of Time Charter Employment for Two VLCC Tankers
VVOS

GlobeNewswire

a year ago

TOP Ships Inc. Announces Extension of Time Charter Employment for Two VLCC Tankers

VVOS

GlobeNewswire

a year ago

Kaixin Auto Holdings Announces Supplements to Unaudited First Half 2023 Financial Results

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
VVOS

GlobeNewswire

a year ago

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results
VVOS

GlobeNewswire

a year ago

Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results

AgeX Therapeutics Reports Third Quarter 2023 Financial Results
VVOS

Business Wire

a year ago

AgeX Therapeutics Reports Third Quarter 2023 Financial Results

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
VVOS

GlobeNewswire

a year ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

AGBA Group Releases Third Quarter 2023 Financial Results
VVOS

GlobeNewswire

a year ago

AGBA Group Releases Third Quarter 2023 Financial Results

VVOS

Associated Press Finance

a year ago

Talis: Q3 Earnings Snapshot

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
VVOS

GlobeNewswire

a year ago

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

Mobile Infrastructure Reports Third Quarter 2023 Financial Results
VVOS

Business Wire

a year ago

Mobile Infrastructure Reports Third Quarter 2023 Financial Results

VVOS

Associated Press Finance

a year ago

VTv Therapeutics: Q3 Earnings Snapshot

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
VVOS

GlobeNewswire

a year ago

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt
VVOS

Business Wire

a year ago

Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt

VVOS

Associated Press Finance

a year ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
VVOS

PR Newswire

a year ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
VVOS

GlobeNewswire

a year ago

vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference

While insiders are yet to place a huge wager on Kaixin Auto Holdings (NASDAQ:KXIN), retail investors saw 11% gain on holdings value last week
VVOS

Simply Wall St.

a year ago

While insiders are yet to place a huge wager on Kaixin Auto Holdings (NASDAQ:KXIN), retail investors saw 11% gain on holdings value last week

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement
VVOS

Simply Wall St.

a year ago

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement

Share on Social Networks: